Close Menu

Breaking News

The five-year gift will support the building and maintenance of the NYGC's genomics infrastructure to work with its institutional founding members.

The researchers found that two subtypes of combined hepatocellular and intrahepatic cholangiocarcinoma have distinct molecular features.

The company, which is also backed by Health Innovation Manchester, aims to expedite the commercialization of biomarkers into new diagnostic tests.

The Cobas TV/MG test detects Trichomonas vaginalis (TV) and Mycoplasma genitalium (MG) DNA in symptomatic and asymptomatic patients.

The Hologic Aptima Combo 2 and the Cepheid Xpert CT/NG assays have now been cleared for use in throat and rectum samples.

The firm plans to use the funds raised to support business activities, as it moves forward in the development of cancer early detection tests.

 

With a large genome-wide association study, researchers identified several significant associations in PDE4B, a gene with expression shifts in brain samples from stressed mice.

The Australian firm will use the proceeds for R&D, expansion in China, and to fund the development of polygenic risk tests with TGen in the US.

The California-based health system is expanding its partnership with clinical decision support vendor CancerIQ to integrate risk assessment into the Cerner EHR workflow.

Using exome sequencing, the team developed a transgenic model with altered orthologs of nine genes and found a combination of drugs that could act as a cancer treatment option.

With exome sequences from more than 600 metastatic breast tumors, researchers identified genomic alterations related to tumor progression, treatment response, and patient outcomes.

The firm said that it may use some of the net proceeds to acquire or invest in complementary businesses and technologies.

With exome sequences from tens of thousands of T2D cases or controls from five ancestral groups, researchers identified genes that are frequently impacted by rare T2D-linked variants.

The commission will develop a framework for scientists, clinicians, and regulatory authorities on the appropriate use of human germline genome editing. 

The company will now be able to market the test, which algorithmically weighs molecular markers and clinical information, in all 50 US states.

The researchers traced the timing of when these clusters developed to the emergence of agriculture in three river valleys.

A company executive confirmed that Helix has laid off an undisclosed number of employees and is closing its Denver and San Francisco offices.

The group will define and quantify Stroma Liquid Biopsy biomarkers in Leiden University-collected sera to correlate them with Leiden's tumor-stroma ratio scoring methods.

MammaPrint classifies patients as either high risk or low risk of recurrence over a 10-year period while BluePrint classifies patients by breast cancer subtype.

The two-year award will fund development and commercialization of the firm's HLS-Catch platform and follows a previous grant of $191,535.

The company estimated that the offering could raise between $327.2 and $376.3 million, which it would use for various corporate purposes.

The company, based in Fort Myers, Florida, said that it plans to use the net proceeds from the offering for general corporate purposes.

The funds will support Curetis' R&D efforts, which include partnering its Unyvero A30 RQ mid-plex diagnostics system for verification and validation testing.

The decrease came as improved performance by its biopharma services operations was more than offset by declines in clinical and discovery services revenues.

Shares jumped nearly 90 percent today after the firm said this morning that it has commercially launched its Target Selector NGS Lung Panel assay.

Pages

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.